In this special edition of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Michelle Lim, MD; Davinder Grover, MD; and James Brandt, MD, analyze their experience with the MicroShunt-a controlled micro-incisional ab-externo glaucoma filtration surgery device. Together, they share their surgical procedures and pearls, how to deal with the complications of post-op blebs, and proper mitomycin dosage based on the recent INN005 clinical trial findings.1  

1. Baker ND, Barnebey HS, Moster MR, et al; INN005 study group. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: 1-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021 :S0161-6420(21 )00384-00385.